These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
    Author: Tsuchida K, Yamazaki R, Kaneko K, Aihara H.
    Journal: Arzneimittelforschung; 1987 Nov; 37(11):1239-43. PubMed ID: 3481545.
    Abstract:
    2-Nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitropheny l)- 1,4-dihydropyridine-3,5-dicarboxylate (CD-349), nimodipine and nicardipine (0.3-3 micrograms/kg i.v.) increased vertebral blood flow (VBF) in the anesthetized dog, the effect of CD-349 being the strongest, and they also decreased blood pressure. All these drugs slightly increased femoral blood flow. CD-349, nimodipine and nicardipine (1-10 micrograms/kg i.v.) increased cerebral tissue blood flow (CBF) in the anesthetized dog, CD-349 producing the most sustained and pronounced effect. CD-349 (3 micrograms/kg i.v.) restored the decrease of CBF induced by the application of 0.5 ml of serotonin (5-HT, 10(-5) mol/l), KCl (30 mmol/l) and prostaglandin F2 alpha (PGF2 alpha, 10(-4) mol/l) to the surface of the cerebrum of the anesthetized dog. In isolated canine basilar arteries. K-contraction was completely inhibited, but the relaxation of 5-HT- and PGF2 alpha-contractions by these drugs was incomplete. CD-349 had a more potent effect than nicardipine and nimodipine on basilar arteries. These results indicate that CD-349 is a potent cerebrovasodilator.
    [Abstract] [Full Text] [Related] [New Search]